Featured Research

from universities, journals, and other organizations

Toxicologist says NAS panel 'misled the world' when adopting radiation exposure guidelines

Date:
August 13, 2013
Source:
University of Massachusetts at Amherst
Summary:
A toxicologist describes how regulators came to adopt the linear no threshold (LNT) dose-response approach to ionizing radiation exposure in the 1950s, which was later generalized to chemical carcinogen risk assessment. He also offers further evidence to support his earlier assertions that two geneticists deliberately suppressed evidence to prevent the U.S. National Academy of Sciences from considering an alternative, threshold model, for which there was experimental support.

In two recently published peer-reviewed articles, toxicologist Edward Calabrese of the University of Massachusetts Amherst describes how regulators came to adopt the linear no threshold (LNT) dose-response approach to ionizing radiation exposure in the 1950s, which was later generalized to chemical carcinogen risk assessment.

Related Articles


He also offers further evidence to support his earlier assertions that two geneticists deliberately suppressed evidence to prevent the U.S. National Academy of Sciences (NAS) from considering an alternative, threshold model, for which there was experimental support. Calabrese's articles appear in the July 26 and August 4 issues of Archives of Toxicology.

Calabrese says, "The regulatory research community needs to hear about this. This isn't an academic debate; it's practical, because all of our rules about chemical and low-level radiation are based on unvalidated assumptions and scientific panel decisions made without sound evidence. Now, after all these years, it's very hard when people have been frightened to death of any exposure whatsoever, to persuade them that we don't need to be scared by certain low-dose exposures."

The first of Calabrese's recent articles is a straightforward history of the LNT model for ionizing radiation mutation, a concept accepted by radiation geneticists in the 1950s and recommended by national and international advisory committees for risk assessment and human exposure guidelines and later generalized to chemical carcinogens ever since. It is now used by public health and regulatory agencies worldwide, he notes.

In the second of the two articles, Calabrese repeats his earlier accusations that the distinguished radiation geneticist Hermann Muller, in his acceptance speech for the 1946 Nobel Prize, "made deceptive statements" intended to "promote the acceptance of the linear dose-response model for risk assessment for ionizing radiation" and that Muller's advocacy agenda was "masked" by long-time colleague Curt Stern. Their actions affected "key publications in the mutation literature," enhancing acceptance of the linear dose-response and hiding "Muller's deceptions," Calabrese adds.

His own career-long research on hormesis, which is a non-linear, threshold-based or biphasic approach to dose-response and risk assessment for ionizing radiation and toxic chemicals, provides evidence that low-dose exposure of some chemicals and ionizing radiation are benign or even helpful. In three "substantial validation tests" of the threshold, hormesis and linear no-threshold models, Calabrese and colleagues say, "only the hermetic (biphasic) dose-response made consistently accurate predictions."

The UMass Amherst toxicologist has argued for many years that a reappraisal of cancer risk assessment methods is urgently needed because the LNT model was incorporated into U.S. regulatory policy based on faulty assumptions and by Muller and Stern's manipulation of the scientific literature.

Calabrese's interpretation of this history is supported by letters and other materials he has compiled, many from formerly classified files. Muller and Stern had done many of the key experiments contributing to health risk assessment of ionizing radiation and Muller served on NAS's Biological Effects of Atomic Radiation (BEAR) committee through which the linear dose-response approach to risk assessment became firmly entrenched, Calabrese related. He offers further evidence that the two successfully suppressed evidence from a key experiment with fruit fly sperm that challenged their views on dose-response.


Story Source:

The above story is based on materials provided by University of Massachusetts at Amherst. Note: Materials may be edited for content and length.


Journal References:

  1. Edward J. Calabrese. How the US National Academy of Sciences misled the world community on cancer risk assessment: new findings challenge historical foundations of the linear dose response. Archives of Toxicology, 2013; DOI: 10.1007/s00204-013-1105-6
  2. Edward J. Calabrese. Origin of the linearity no threshold (LNT) dose–response concept. Archives of Toxicology, 2013; DOI: 10.1007/s00204-013-1104-7

Cite This Page:

University of Massachusetts at Amherst. "Toxicologist says NAS panel 'misled the world' when adopting radiation exposure guidelines." ScienceDaily. ScienceDaily, 13 August 2013. <www.sciencedaily.com/releases/2013/08/130813201434.htm>.
University of Massachusetts at Amherst. (2013, August 13). Toxicologist says NAS panel 'misled the world' when adopting radiation exposure guidelines. ScienceDaily. Retrieved March 5, 2015 from www.sciencedaily.com/releases/2013/08/130813201434.htm
University of Massachusetts at Amherst. "Toxicologist says NAS panel 'misled the world' when adopting radiation exposure guidelines." ScienceDaily. www.sciencedaily.com/releases/2013/08/130813201434.htm (accessed March 5, 2015).

Share This


More From ScienceDaily



More Health & Medicine News

Thursday, March 5, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Bupa Eyes India Healthcare Opportunities

Bupa Eyes India Healthcare Opportunities

Reuters - Business Video Online (Mar. 5, 2015) — Bupa is hoping to expand in India&apos;s fast-growing health insurance market, once a rule change on foreign investment is implemented. The British private healthcare group&apos;s CEO tells Grace Pascoe why it&apos;s so keen on the new opportunity. Video provided by Reuters
Powered by NewsLook.com
Doctor in Your Pocket Is Getting Smarter

Doctor in Your Pocket Is Getting Smarter

Reuters - Business Video Online (Mar. 5, 2015) — Mobile apps are turning smartphones into a personal doctors, with users able to measure heart rate, blood pressure and even blood sugar. But will it change our behaviour? Ivor Bennett reports from the Mobile World Congress in Barcelona. Video provided by Reuters
Powered by NewsLook.com
AbbVie Inks $21B Deal To Buy Cancer Drugmaker Pharmacyclics

AbbVie Inks $21B Deal To Buy Cancer Drugmaker Pharmacyclics

Newsy (Mar. 5, 2015) — AbbVie announced Wednesday it will buy cancer drugmaker Pharmacyclics in a $21 billion deal. Video provided by Newsy
Powered by NewsLook.com
Adults Only Get The Flu Twice A Decade, Researchers Say

Adults Only Get The Flu Twice A Decade, Researchers Say

Newsy (Mar. 4, 2015) — Researchers found adults only get the flu about once every five years. Scientists analyzed how a person&apos;s immunity builds up over time as well. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins